A U.S. federal jury in California ruled that Apple must pay Masimo $634 million for infringing the company’s blood-oxygen monitoring patent used in Apple Watch features. Apple said it will appeal, while Masimo called the decision a major victory.
The verdict is part of a larger patent battle between the two companies, which has already led to a temporary import ban on Apple’s smartwatches and ongoing disputes before U.S. trade authorities and federal courts. Both sides continue to pursue multiple related lawsuits, including Masimo’s case over Apple allegedly stealing its pulse-oximetry technology and Apple’s challenges to the import restrictions.
Credit : CGTN